Named on one round in the feed.
Since 2026-08-27
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
AusperBio Therapeutics, Inc. A startup developing therapeutics for chronic hepatitis B and other diseases | Series C Verified against 4 of 8 sources | $120M | 2026-08-27 | [ PART ] |